Cutimed® Sorbact® is highly effective against common wound bacteria and multi-drug resistant bacteria including MRSA2 and VRE, but also targets fungi. Potentially reducing the need for systemic antibiotics. Unlike bactericidal substances that kill bacteria, development of bacterial resistance is not expected with the mode of action of Cutimed® Sorbact® and can be used prophylactically Cutimed ®Sorbact® has been shown to: Reduces bioburden in wounds. No release of active substances into the wound? bed Does not promote the bacterial release of endotoxins. Development of bacterial or fungal resistance is not expected? No known contraindications and low risk of allergies? No limitation in treatment time